Alan F. Schatzberg, M.D.

Article

Introduction. Pharmacologic Treatments of Major Depression: Are Two Mechanisms Really Better Than One?

March 1, 2004

Article

Introduction: Treating Depression and Anxiety to Remission

October 1, 2003

Article

Introduction: Treating Depression and Anxiety to Remission

October 1, 2003

Article

Introduction: Recent Developments in Achieving Depression Remission

October 1, 2003

Article

Efficacy and Tolerability of Duloxetine, a Novel Dual Reuptake Inhibitor, in the Treatment of Major Depressive Disorder

October 1, 2003

Original Research

Depression-Free Days as a Summary Measure of the Temporal Pattern of Response and Remission in the Treatment of Major Depression: A Comparison of Venlafaxine, Selective Serotonin Reuptake Inhibitors, and Placebo

March 15, 2003

Article

New Approaches to Managing Psychotic Depression

January 1, 2003

Article

New Approaches to Managing Psychotic Depression

January 1, 2003

Original Research

Differential Effects of Nefazodone and Cognitive Behavioral Analysis System of Psychotherapy on Insomnia Associated With Chronic Forms of Major Depression

June 18, 2002

Article

Clinical Use of Nefazodone in Major Depression: A 6-Year Perspective. Use of Nefazodone in Major Depression

January 1, 2002

Letter to the Editor

Reply to Letter to the Editor "Should We Keep Calling Antidepressants Antidepressants?"

October 1, 2001

Article

New Indications for Antidepressants

September 30, 2000